Sudarshan Pharma Industries Ltd.
Fundamentals
- Market cap
- ₹985 cr
- P/E
- 42.25×
- ROE
- 12.14%
- Debt / equity
- 1.30
- 52-week range
- 18.50 — 40.41
Company snapshot
Sudarshan Pharma Industries Ltd.
Pharmaceuticals
₹985 cr
P/E 42.25×
Latest quarter · Mar 2026
Sales₹221 cr
Net profit₹11 cr
Op. margin+9.1%
EPS₹0.45
Strength & growth
Debt / equity1.30×
Current ratio1.29×
The timeline — 2 notes on Sudarshan Pharma Industries Ltd.
June 2026
- 15 Jun 26 · 7:22 PM IST Brief Brief · Micro cap
Sudarshan Pharma board to weigh fund raise on June 18
The micro-cap drugmaker will discuss equity, convertible, or debt options, but the size, structure, and pricing remain undisclosed — leaving dilution or debt risk unclear.
- 12 Jun 26 · 8:03 PM IST Lead Lead · Credit · Micro cap
Sudarshan Pharma promoters convert warrants, lift stake to 58.93%
Promoters exercise warrants for 90 lakh shares at ₹16.98, infusing ₹11.46 crore. Stake jumps from 26.6% to 58.93%.